Profile
Janet Horton is currently Vice President & Head-Clinical Development at Aktis Oncology, Inc. since 2022.
Formerly, Dr. Horton was Head-Program Management at Brii Biosciences, Inc. Dr. Horton completed undergraduate studies at the University of East London.
Janet Horton active positions
| Companies | Position | Start |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2022-07-31 |
Former positions of Janet Horton
| Companies | Position | End |
|---|---|---|
Brii Biosciences, Inc.
Brii Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops therapies | Corporate Officer/Principal | - |
Training of Janet Horton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of East London
University of East London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Brii Biosciences, Inc.
Brii Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops therapies | Commercial Services |
- Stock Market
- Insiders
- Janet Horton
















